Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M FONTAINE

Showing results (291-300 of 340) with videos related to

Pageof 34
Sort By:
European Journal of Cancer & Clinical Oncology|February 1, 1983
Antimelanoma hybridoma antibodies against partially purified melanoma antigenL Medrano, J P Cesarini, M Daveau, et al.
Bulletin Des Societes D'Ophtalmologie De France|April 1, 1984
[Ophthalmoscopic manifestations observed in AIDS]P Le Hoang, J C Piette, W Rozembaum, et al.
ACS Nano|January 14, 2016
Probing Bioluminescence Resonance Energy Transfer in Quantum Rod-Luciferase NanoconjugatesRabeka Alam, Liliana M Karam, Tennyson L Doane, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|November 1, 1973
[Anatomical study of 2 acephalic acardiac monsters (classification and physiopathological hypotheses)]J H Soutoul, P Grosieux, C Berger, et al.
European Journal of Pediatrics|August 1, 1994
Stroke, hemiparesis and deficient mitochondrial beta-oxidationL Vallée, M Fontaine, J P Nuyts, et al.
Journal of Bacteriology|October 18, 2021
Cellular Effects of 2',3'-Cyclic Nucleotide Monophosphates in Gram-Negative BacteriaYashasvika Duggal, Jennifer E Kurasz, Benjamin M Fontaine, et al.
Biochemistry|September 28, 2019
Mutagenesis and Structural Studies Reveal the Basis for the Activity and Stability Properties That Distinguish the <i>Photinus</i> Luciferases <i>scintillans</i> and <i>pyralis</i>Bruce R Branchini, Danielle M Fontaine, Tara L Southworth, et al.
European Journal of Immunology|July 1, 1996
Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23V Frémeaux-Bacchi, I Bernard, F Maillet, et al.
Frontiers in Microbiology|April 8, 2017
Identification of Ellagic Acid Rhamnoside as a Bioactive Component of a Complex Botanical Extract with Anti-biofilm ActivityBenjamin M Fontaine, Kate Nelson, James T Lyles, et al.
Journal Des Maladies Vasculaires|January 1, 1996
[Chronic venous insufficiency 7 to 10 years after partial vena cava interruption with a clip]M Fontaine, J L Bosson, Y Bourgin, et al.
Pageof 34

Showing results (291-300 of 340) with videos related to

Sort By:
Pageof 34
European Journal of Cancer & Clinical Oncology|February 1, 1983
Antimelanoma hybridoma antibodies against partially purified melanoma antigenL Medrano, J P Cesarini, M Daveau, et al.
Bulletin Des Societes D'Ophtalmologie De France|April 1, 1984
[Ophthalmoscopic manifestations observed in AIDS]P Le Hoang, J C Piette, W Rozembaum, et al.
ACS Nano|January 14, 2016
Probing Bioluminescence Resonance Energy Transfer in Quantum Rod-Luciferase NanoconjugatesRabeka Alam, Liliana M Karam, Tennyson L Doane, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|November 1, 1973
[Anatomical study of 2 acephalic acardiac monsters (classification and physiopathological hypotheses)]J H Soutoul, P Grosieux, C Berger, et al.
European Journal of Pediatrics|August 1, 1994
Stroke, hemiparesis and deficient mitochondrial beta-oxidationL Vallée, M Fontaine, J P Nuyts, et al.
Journal of Bacteriology|October 18, 2021
Cellular Effects of 2',3'-Cyclic Nucleotide Monophosphates in Gram-Negative BacteriaYashasvika Duggal, Jennifer E Kurasz, Benjamin M Fontaine, et al.
Biochemistry|September 28, 2019
Mutagenesis and Structural Studies Reveal the Basis for the Activity and Stability Properties That Distinguish the <i>Photinus</i> Luciferases <i>scintillans</i> and <i>pyralis</i>Bruce R Branchini, Danielle M Fontaine, Tara L Southworth, et al.
European Journal of Immunology|July 1, 1996
Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23V Frémeaux-Bacchi, I Bernard, F Maillet, et al.
Frontiers in Microbiology|April 8, 2017
Identification of Ellagic Acid Rhamnoside as a Bioactive Component of a Complex Botanical Extract with Anti-biofilm ActivityBenjamin M Fontaine, Kate Nelson, James T Lyles, et al.
Journal Des Maladies Vasculaires|January 1, 1996
[Chronic venous insufficiency 7 to 10 years after partial vena cava interruption with a clip]M Fontaine, J L Bosson, Y Bourgin, et al.
Pageof 34